Corporate
-
A Leader in Venture Financings
Wilson Sonsini is ranked as the No. 1 law firm in the U.S. and globally based on the number of company-side venture financing rounds raised for clients in 2025. (Source: LSEG Global Legal Private Equity and Venture Capital Review, Full Year 2025)
-
Ranked Among the Top Capital Markets Advisors to Companies and Underwriters
We are consistently ranked by Bloomberg, Thomson Reuters, and CapitalIQ as a leading advisor to companies and underwriters based on the number of completed IPOs and equity and equity-linked offerings. Over the past 20 years, the firm has represented some of the world’s most iconic companies in such transactions, including Google, LinkedIn, Twitter, and Lyft.
-
Advise on Hundreds of M&A Deals Annually
In 2025, Wilson Sonsini advised on more than 150 announced and/or completed M&A deals with an aggregate disclosed value of $100 billion.
Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and growth enterprises worldwide, as well as the venture firms, private equity firms, and investment banks that finance them. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations. The firm's attorneys collaborate across a comprehensive range of practice areas and industry groups to help the management, boards of directors, shareholders, and in-house counsel of our clients address their most pressing challenges and pursue their most promising opportunities.
Wilson Sonsini is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Our services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, employee benefits, and other corporate transactional areas.
Our clients are companies and other entities that compete in rapidly developing and innovative industries, including the biotech, communications, digital media, energy, financial services, medical devices, and software sectors.
Overview
Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and growth enterprises worldwide, as well as the venture firms, private equity firms, and investment banks that finance them. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations. The firm's attorneys collaborate across a comprehensive range of practice areas and industry groups to help the management, boards of directors, shareholders, and in-house counsel of our clients address their most pressing challenges and pursue their most promising opportunities.
Wilson Sonsini is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Our services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, employee benefits, and other corporate transactional areas.
Our clients are companies and other entities that compete in rapidly developing and innovative industries, including the biotech, communications, digital media, energy, financial services, medical devices, and software sectors.
Client Highlights
Wilson Sonsini Advises Xapien on $56 Million Series B
On September 11, 2026, Xapien, an AI-native due diligence platform, announced a $56 million Series B investment round led by Spectrum Equity, with continued support from existing investor YFM Equity Partners. Wilson Sonsini Goodrich & Rosati advised Xapien on the transaction.
Client Highlights
Firm Advises Frontier Computing on $10 Million Pre-Seed Round
On September 1, 2026, Frontier Computing announced that it has raised $10 million in a pre-seed round of financing. The round was led by General Catalyst, with participation from Amino Collective, LocalGlobe, Kaya, and Long Journey Ventures. Wilson Sonsini Goodrich & Rosati advised Frontier Computing on the transaction.
The UK-based start-up is growing the first biological brain systems at scale for machine learning training and inference workloads. Led by Cambridge natural scientist Michael Domarkas, the company says it has solved the vascularization problem that keeps academic brain organoids below 1 million neurons.
The Wilson Sonsini team that advised Frontier on the financing included Brad Doline, Michael Labriola, and Liam Holohan.
For more information, please see this article from Dealroom.co.
The UK-based start-up is growing the first biological brain systems at scale for machine learning training and inference workloads. Led by Cambridge natural scientist Michael Domarkas, the company says it has solved the vascularization problem that keeps academic brain organoids below 1 million neurons.
The Wilson Sonsini team that advised Frontier on the financing included Brad Doline, Michael Labriola, and Liam Holohan.
For more information, please see this article from Dealroom.co.
Client Highlights
Wilson Sonsini Advises GCVC Fund on Launch
On September 8, 2026, early-stage venture fund GCVC, backed by more than 50 sitting general counsels from prominent private and public companies, announced its launch. Wilson Sonsini Goodrich & Rosati is the first law firm to invest in the fund, and the firm’s Fund Services group, led by Brad Doline, represented GCVC in the transaction.
Client Highlights
Wilson Sonsini Advises Autodesk on $1 Billion Senior Notes Offering
On September 10, 2026, Autodesk, Inc., completed its offering of $500 million aggregate principal amount of 5.050 percent senior notes due 2029 and $500 million aggregate principal amount of 5.650 percent senior notes due 2033 (together, the “Notes”). Autodesk intends to use the net proceeds from the sale of the Notes, together with cash on hand, to repay $1 billion aggregate principal amount under its existing term loan credit agreement. Wilson Sonsini Goodrich & Rosati advised Autodesk on the transaction.
Client Highlights
Wilson Sonsini Advises Copart on Acquisition of ACV
On September 10, 2026, Copart, Inc., a global leader in online vehicle auctions, and ACV, a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced a definitive agreement in which Copart will acquire all outstanding shares of ACV common stock, valued at approximately $1.9 billion. Wilson Sonsini Goodrich & Rosati advised Copart on the transaction.
Client Highlights
Wilson Sonsini Advises Fab2, Inc. on $500 Million Series A Financing at $3.7 Billion Valuation
On September 9, 2026, Fab2, Inc. (f/k/a Atomic Semi, Inc.) a semiconductor start-up that builds and mass-produces small chip fabs, announced the closing of a $500 million Series A financing led by Fundomo at a $3.7 billion valuation. Corner Capital, Paradigm, Duquesne Family Office, Maverick Silicon, StepStone Group, Protagonist, UDC Ventures, and angel investor Naval Ravikant also joined. Wilson Sonsini Goodrich & Rosati advised Fab2 on the transaction.
Insights
Client Highlights
Wilson Sonsini Advises Xapien on $56 Million Series B
On September 11, 2026, Xapien, an AI-native due diligence platform, announced a $56 million Series B investment round led by Spectrum Equity, with continued support from existing investor YFM Equity Partners. Wilson Sonsini Goodrich & Rosati advised Xapien on the transaction.
Client Highlights
Firm Advises Frontier Computing on $10 Million Pre-Seed Round
On September 1, 2026, Frontier Computing announced that it has raised $10 million in a pre-seed round of financing. The round was led by General Catalyst, with participation from Amino Collective, LocalGlobe, Kaya, and Long Journey Ventures. Wilson Sonsini Goodrich & Rosati advised Frontier Computing on the transaction.
The UK-based start-up is growing the first biological brain systems at scale for machine learning training and inference workloads. Led by Cambridge natural scientist Michael Domarkas, the company says it has solved the vascularization problem that keeps academic brain organoids below 1 million neurons.
The Wilson Sonsini team that advised Frontier on the financing included Brad Doline, Michael Labriola, and Liam Holohan.
For more information, please see this article from Dealroom.co.
The UK-based start-up is growing the first biological brain systems at scale for machine learning training and inference workloads. Led by Cambridge natural scientist Michael Domarkas, the company says it has solved the vascularization problem that keeps academic brain organoids below 1 million neurons.
The Wilson Sonsini team that advised Frontier on the financing included Brad Doline, Michael Labriola, and Liam Holohan.
For more information, please see this article from Dealroom.co.
Client Highlights
Wilson Sonsini Advises GCVC Fund on Launch
On September 8, 2026, early-stage venture fund GCVC, backed by more than 50 sitting general counsels from prominent private and public companies, announced its launch. Wilson Sonsini Goodrich & Rosati is the first law firm to invest in the fund, and the firm’s Fund Services group, led by Brad Doline, represented GCVC in the transaction.
Client Highlights
Wilson Sonsini Advises Autodesk on $1 Billion Senior Notes Offering
On September 10, 2026, Autodesk, Inc., completed its offering of $500 million aggregate principal amount of 5.050 percent senior notes due 2029 and $500 million aggregate principal amount of 5.650 percent senior notes due 2033 (together, the “Notes”). Autodesk intends to use the net proceeds from the sale of the Notes, together with cash on hand, to repay $1 billion aggregate principal amount under its existing term loan credit agreement. Wilson Sonsini Goodrich & Rosati advised Autodesk on the transaction.
Client Highlights
Wilson Sonsini Advises Copart on Acquisition of ACV
On September 10, 2026, Copart, Inc., a global leader in online vehicle auctions, and ACV, a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced a definitive agreement in which Copart will acquire all outstanding shares of ACV common stock, valued at approximately $1.9 billion. Wilson Sonsini Goodrich & Rosati advised Copart on the transaction.
Client Highlights
Wilson Sonsini Advises Fab2, Inc. on $500 Million Series A Financing at $3.7 Billion Valuation
On September 9, 2026, Fab2, Inc. (f/k/a Atomic Semi, Inc.) a semiconductor start-up that builds and mass-produces small chip fabs, announced the closing of a $500 million Series A financing led by Fundomo at a $3.7 billion valuation. Corner Capital, Paradigm, Duquesne Family Office, Maverick Silicon, StepStone Group, Protagonist, UDC Ventures, and angel investor Naval Ravikant also joined. Wilson Sonsini Goodrich & Rosati advised Fab2 on the transaction.
Speaking Engagements
PLI's Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings 2026
Practising Law Institute (PLI) features specialized sessions on tax strategies for financially troubled businesses within its premier annual conference series on Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings. These programs focus on navigating net operating losses (NOLs), debt restructurings, and corporate distress under complex federal tax rules.
Affiliated Programs
The 42nd Annual TEI-SJSU High Tech Tax Institute
Wilson Sonsini is proud to sponsor the annual TEI-SJSU High Tech Tax Institute, a two-day conference held every November. The 42nd Annual Institute offers a deep dive into key tax topics relevant to high tech companies. This in-person event is designed for tax pros from corporate tax departments, CPA and law firms, the IRS, and state tax agencies who deal with high tech businesses. This year's topics include recent guidance and strategies related to significant technology M&A transactions and best M&A tax practices. Wilson Sonsini partner Myra Sutanto Shen will speak on the latest in M&A technology strategies, data centers, and more.
Affiliated Programs
Swedish Chamber of Commerce's Nordic Venture Capital Reception
Join Wilson Sonsini and The Swedish Chamber of Commerce for the Nordic Venture Capital Reception – an intimate evening of peer-level conversation -- with a curated agenda on the themes shaping venture today -- and plenty of time to connect.
WSGR Events
Wilson Sonsini Biotech Summit 2026
We invite you to join us for Wilson Sonsini's Third Annual Biotech Summit. This dynamic, high-profile event will convene leaders from across the biotech industry, including prominent investors, CEOs, founders, key decision makers, and researchers.
Affiliated Programs
East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Events
Speaking Engagements
PLI's Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings 2026
Practising Law Institute (PLI) features specialized sessions on tax strategies for financially troubled businesses within its premier annual conference series on Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings. These programs focus on navigating net operating losses (NOLs), debt restructurings, and corporate distress under complex federal tax rules.
Affiliated Programs
The 42nd Annual TEI-SJSU High Tech Tax Institute
Wilson Sonsini is proud to sponsor the annual TEI-SJSU High Tech Tax Institute, a two-day conference held every November. The 42nd Annual Institute offers a deep dive into key tax topics relevant to high tech companies. This in-person event is designed for tax pros from corporate tax departments, CPA and law firms, the IRS, and state tax agencies who deal with high tech businesses. This year's topics include recent guidance and strategies related to significant technology M&A transactions and best M&A tax practices. Wilson Sonsini partner Myra Sutanto Shen will speak on the latest in M&A technology strategies, data centers, and more.
Affiliated Programs
Swedish Chamber of Commerce's Nordic Venture Capital Reception
Join Wilson Sonsini and The Swedish Chamber of Commerce for the Nordic Venture Capital Reception – an intimate evening of peer-level conversation -- with a curated agenda on the themes shaping venture today -- and plenty of time to connect.
WSGR Events
Wilson Sonsini Biotech Summit 2026
We invite you to join us for Wilson Sonsini's Third Annual Biotech Summit. This dynamic, high-profile event will convene leaders from across the biotech industry, including prominent investors, CEOs, founders, key decision makers, and researchers.
Affiliated Programs
East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Lester Ang
Partner
Lester Ang is a corporate and securities partner in the Palo Alto office of Wilson Sonsini, where he works with private and public technology and life sciences companies through all stages of their growth, as well as with venture capital firms and private equity firms.
Brian Appel
Partner
Brian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
Mark Bass
Partner
Mark Bass is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth. He also represents venture capital funds, private equity firms, and investment banks in financings and public offerings.
Mark B. Baudler
Partner
Mark is a corporate law veteran, having advised start-ups and mature public companies for more than 25 years.
Steven V. Bernard
Partner
Steve has represented non-U.S. and domestic companies in U.S. IPOs, global securities offerings, cross-border M&A, and SEC compliance for more than 25 years.
Ashmi Bhagani
Partner
Ashmi Bhagani is a partner in the London office of Wilson Sonsini Goodrich & Rosati, where she has a diverse transatlantic corporate and securities practice focused on the technology and life sciences sectors.
Richard C. Blake
Partner
Richard has a comprehensive corporate law background, with extensive experience in public offerings.
Lance E. Brady
Partner
Lance Brady is a partner in Wilson Sonsini Goodrich & Rosati's Palo Alto office, where his practice focuses on representing public and private life sciences and technology companies through all stages of their growth. Lance advises his clients on a broad variety of transactions and corporate matters, including initial formation and organization, equity and debt financings, mergers and acquisitions, public offerings, spin-outs, corporate governance, SEC compliance and public company reporting requirements. He also has extensive experience representing venture capital and other institutional investors in financing transactions.
Jason Breen
Partner
Jason Breen is a partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati, where he represents public and private companies at all stages of growth in M&A transactions, primarily working with clients in the life sciences and technology industries. Jason also represents venture capital, growth equity, and private equity funds and focuses on other strategic transactions, including divestitures, joint ventures, and financings.
Tamara Brightwell
Partner
Tamara Brightwell is a corporate partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she counsels public company clients on a wide range of regulatory matters and provides securities law advice on complex capital markets transactions.
People
Lester Ang
Partner
Lester Ang is a corporate and securities partner in the Palo Alto office of Wilson Sonsini, where he works with private and public technology and life sciences companies through all stages of their growth, as well as with venture capital firms and private equity firms.
Brian Appel
Partner
Brian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
Mark Bass
Partner
Mark Bass is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth. He also represents venture capital funds, private equity firms, and investment banks in financings and public offerings.
Mark B. Baudler
Partner
Mark is a corporate law veteran, having advised start-ups and mature public companies for more than 25 years.
Steven V. Bernard
Partner
Steve has represented non-U.S. and domestic companies in U.S. IPOs, global securities offerings, cross-border M&A, and SEC compliance for more than 25 years.
Ashmi Bhagani
Partner
Ashmi Bhagani is a partner in the London office of Wilson Sonsini Goodrich & Rosati, where she has a diverse transatlantic corporate and securities practice focused on the technology and life sciences sectors.
Richard C. Blake
Partner
Richard has a comprehensive corporate law background, with extensive experience in public offerings.
Lance E. Brady
Partner
Lance Brady is a partner in Wilson Sonsini Goodrich & Rosati's Palo Alto office, where his practice focuses on representing public and private life sciences and technology companies through all stages of their growth. Lance advises his clients on a broad variety of transactions and corporate matters, including initial formation and organization, equity and debt financings, mergers and acquisitions, public offerings, spin-outs, corporate governance, SEC compliance and public company reporting requirements. He also has extensive experience representing venture capital and other institutional investors in financing transactions.
Jason Breen
Partner
Jason Breen is a partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati, where he represents public and private companies at all stages of growth in M&A transactions, primarily working with clients in the life sciences and technology industries. Jason also represents venture capital, growth equity, and private equity funds and focuses on other strategic transactions, including divestitures, joint ventures, and financings.
Tamara Brightwell
Partner
Tamara Brightwell is a corporate partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she counsels public company clients on a wide range of regulatory matters and provides securities law advice on complex capital markets transactions.
Related Practices
- Capital Markets
- Corporate Governance
- Corporate Life Sciences
- Emerging Companies and Venture Capital
- Employee Benefits and Compensation
- Energy and Climate Solutions
- Finance and Structured Finance
- Fund Formation
- Greater China
- Life Sciences Business Advisory Practice
- Mergers & Acquisitions
- Private Equity
- Public Company Representation
- Real Estate
- Restructuring
- Shareholder Engagement and Activism
- Special Purpose Acquisition Companies (SPACs)
- Tax
- U.S. Expansion
Recent Insights
Client Highlights
Wilson Sonsini Advises Xapien on $56 Million Series B
On September 11, 2026, Xapien, an AI-native due diligence platform, announced a $56 million Series B investment round led by Spectrum Equity, with continued support from existing investor YFM Equity Partners. Wilson Sonsini Goodrich & Rosati advised Xapien on the transaction.
Learn More
Client Highlights
Firm Advises Frontier Computing on $10 Million Pre-Seed Round
On September 1, 2026, Frontier Computing announced that it has raised $10 million in a pre-seed round of financing. The round was led by General Catalyst, with participation from Amino Collective, LocalGlobe, Kaya, and Long Journey Ventures. Wilson Sonsini Goodrich & Rosati advised Frontier Computing on the transaction.
The UK-based start-up is growing the first biological brain systems at scale for machine learning training and inference workloads. Led by Cambridge natural scientist Michael Domarkas, the company says it has solved the vascularization problem that keeps academic brain organoids below 1 million neurons.
The Wilson Sonsini team that advised Frontier on the financing included Brad Doline, Michael Labriola, and Liam Holohan.
For more information, please see this article from Dealroom.co.
The UK-based start-up is growing the first biological brain systems at scale for machine learning training and inference workloads. Led by Cambridge natural scientist Michael Domarkas, the company says it has solved the vascularization problem that keeps academic brain organoids below 1 million neurons.
The Wilson Sonsini team that advised Frontier on the financing included Brad Doline, Michael Labriola, and Liam Holohan.
For more information, please see this article from Dealroom.co.
Learn More
Recent Events
Speaking Engagements
PLI's Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings 2026
Practising Law Institute (PLI) features specialized sessions on tax strategies for financially troubled businesses within its premier annual conference series on Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings. These programs focus on navigating net operating losses (NOLs), debt restructurings, and corporate distress under complex federal tax rules.
Learn More
Affiliated Programs
The 42nd Annual TEI-SJSU High Tech Tax Institute
Wilson Sonsini is proud to sponsor the annual TEI-SJSU High Tech Tax Institute, a two-day conference held every November. The 42nd Annual Institute offers a deep dive into key tax topics relevant to high tech companies. This in-person event is designed for tax pros from corporate tax departments, CPA and law firms, the IRS, and state tax agencies who deal with high tech businesses. This year's topics include recent guidance and strategies related to significant technology M&A transactions and best M&A tax practices. Wilson Sonsini partner Myra Sutanto Shen will speak on the latest in M&A technology strategies, data centers, and more.
Learn More
Newsletters
2024 Mid-Year Technology and Life Sciences PIPE and RDO Report
Wilson Sonsini Goodrich & Rosati is pleased to present the 2024 Mid-Year Technology and Life Sciences PIPE and RDO Report, analyzing 124 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based tech and life science companies between January 1 and June 30, 2024.
- Privacy Policy
- Terms of Use
- Accessibility
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.